Community Trust & Investment Co. cut its position in shares of CVS Health Co. (NYSE:CVS – Free Report) by 10.4% in the fourth quarter, Holdings Channel reports. The firm owned 232,496 shares of the pharmacy operator’s stock after selling 26,961 shares during the period. Community Trust & Investment Co.’s holdings in CVS Health were worth $10,437,000 as of its most recent SEC filing.
Several other large investors have also made changes to their positions in CVS. MidAtlantic Capital Management Inc. acquired a new stake in CVS Health in the third quarter valued at approximately $25,000. Ridgewood Investments LLC raised its holdings in shares of CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 450 shares in the last quarter. Livelsberger Financial Advisory acquired a new stake in shares of CVS Health in the 3rd quarter valued at $31,000. Legacy Investment Solutions LLC bought a new stake in CVS Health in the third quarter worth $31,000. Finally, Reston Wealth Management LLC acquired a new position in CVS Health during the third quarter worth $32,000. Institutional investors own 80.66% of the company’s stock.
CVS Health Price Performance
Shares of CVS stock opened at $51.60 on Wednesday. The company has a market capitalization of $64.93 billion, a P/E ratio of 13.10, a P/E/G ratio of 0.85 and a beta of 0.59. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75. The stock has a 50 day moving average of $51.68 and a two-hundred day moving average of $56.44.
CVS Health Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Investors of record on Thursday, January 23rd will be given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 5.16%. The ex-dividend date is Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.
Analyst Upgrades and Downgrades
CVS has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft raised CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price target for the company in a research report on Tuesday, December 3rd. Cantor Fitzgerald restated a “neutral” rating and issued a $62.00 target price on shares of CVS Health in a report on Tuesday, October 1st. StockNews.com downgraded CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. Royal Bank of Canada reduced their price objective on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research note on Friday, November 15th. Finally, Barclays lowered their target price on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a research note on Thursday, November 7th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $68.71.
Read Our Latest Stock Analysis on CVS
CVS Health Company Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Read More
- Five stocks we like better than CVS Health
- Using the MarketBeat Dividend Yield Calculator
- 3 Stocks With Strong Capital Returns and Insider Buying Signals
- Market Cap Calculator: How to Calculate Market Cap
- 3 Affordable Dividend Stocks to Buy Now for Income and Growth
- How to trade using analyst ratings
- The Fed Is More Likely to Hike Than Cut Rates in 2025
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.